Letrozole

Generic name: Letrozole
Brand names: Femara
Dosage form: oral tablet (2.5 mg)

Usage of Letrozole

Letrozole lowers estrogen levels in postmenopausal women, which may slow the growth of certain types of breast tumors that need estrogen to grow in the body.

Letrozole is used to treat breast cancer in postmenopausal women. It is often given to women who have been taking tamoxifen (Nolvadex, Soltamox) for 5 years.

Letrozole may also be used for purposes not listed in this medication guide.

Letrozole side effects

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Common side effects of letrozole may include:

  • hot flashes, warmth or redness in your face or chest;
  • headache, dizziness, weakness;
  • bone pain, muscle or joint pain;
  • swelling, weight gain;
  • increased sweating; or
  • increased cholesterol in your blood.
  • This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

    Before taking Letrozole

    You should not use letrozole if you are allergic to it.

    letrozole is for use only in women who can no longer get pregnant. Letrozole can harm an unborn baby. Do not use if you are pregnant. Use effective birth control if you are not past menopause. Keep using birth control for at least 3 weeks after your last dose of letrozole. Tell your doctor if you think you may be pregnant.

    Tell your doctor if you have ever had:

  • liver disease (especially cirrhosis);
  • osteoporosis, osteopenia (low bone mineral density);
  • high cholesterol; or
  • if you also take tamoxifen.
  • You should not breastfeed while you are using letrozole and for at least 3 weeks after your last dose.

    How to use Letrozole

    Usual Adult Dose for Breast Cancer:

    2.5 mg orally once a dayDuration of therapy:-Adjuvant and extended adjuvant settings: Optimal duration is unknown; discontinue therapy at relapse.-Advanced disease: Until tumor progression is evident.Uses: -Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer-Extended adjuvant treatment of early breast cancer in postmenopausal women who have received 5 years of adjuvant tamoxifen therapy-First-line treatment of advanced breast cancer in postmenopausal women with hormone receptor positive or unknown locally advanced or metastatic breast cancer; second-line treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy

    Usual Adult Dose for Breast Cancer -- Adjuvant:

    2.5 mg orally once a dayDuration of therapy:-Adjuvant and extended adjuvant settings: Optimal duration is unknown; discontinue therapy at relapse.-Advanced disease: Until tumor progression is evident.Uses: -Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer-Extended adjuvant treatment of early breast cancer in postmenopausal women who have received 5 years of adjuvant tamoxifen therapy-First-line treatment of advanced breast cancer in postmenopausal women with hormone receptor positive or unknown locally advanced or metastatic breast cancer; second-line treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy

    Warnings

    You should not use letrozole if you are pregnant.

    What other drugs will affect Letrozole

    Other drugs may affect letrozole, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords